Rx Only

Ready for 24-48h Central Dispatch

In Stock

AZINUS-200 Clinical Monograph & Batch COA

Certified DCGI Formulation Literature (PDF)

Download

SyrupPrescription Required (Schedule Drug)

AZINUS-200

Name: AZINUS-200
Brand: Sygnus Biotech

Active Drug Composition

Azithromycin 200mg Oral Suspension

WHO-GMP Certified Batch ManufacturingDCGI Approved Formulation100% BioavailableAlu-Alu Packaging

AZINUS-200 is a broad-spectrum bactericidal antimicrobial agent exhibiting enhanced pharmacokinetic tissue penetration against susceptible gram-positive and gram-negative pathogens.

Dosage FormOral Liquid Suspension / Syrup

Packaging Presentation100ml / 200ml PET Bottle with Graduated Measuring Cap

B2B Distributor & Healthcare Professional Notice:This product is supplied solely through verified licensed pharmaceutical distributors, stockists, and institutional tenders. Online retail checkout for prescription formulations is legally restricted.

Clinical Pharmacology & Therapeutic Profile

Comprehensive therapeutic guidelines for medical practitioners and institutional procurement

Therapeutic Indications

Lower Respiratory Tract Infections

Acute Bacterial Sinusitis

Urinary Tract Infections (UTI)

Skin and Soft Tissue Infections

Community-Acquired Pneumonia

Mechanism of Action (MOA)

Inhibits bacterial DNA gyrase (type II topoisomerase) and topoisomerase IV enzymes required for bacterial DNA replication, transcription, and repair.

Dosage & Posology

Adult: One dose once or twice daily depending on infectious severity. Complete full course to prevent antimicrobial resistance.

Safety & Precautions

Well tolerated under clinical supervision. Contraindicated in patients with hypersensitivity to active ingredients.

Storage Guidelines

Store below 25°C. Do not freeze. Keep container tightly closed.

WHO-GMP Certified Purity

Manufactured in state-of-the-art HVAC controlled cleanrooms with 100% active ingredient bio-potency and analytical batch testing.

Alu-Alu Moisture Barrier

Superior barrier protection against tropical humidity, preventing physical degradation and guaranteeing 24-month stability.

Exclusive District Monopoly

Strict PCD franchise monopoly allocation ensuring zero price competition and complete territory protection for our partners.

Technical Product Specifications

Therapeutic SegmentSyrup

Dosage FormOral Liquid Suspension / Syrup

Packaging Type100ml / 200ml PET Bottle with Graduated Measuring Cap

Regulatory ScheduleSchedule H

Minimum Order Qty100 Units

Country of OriginIndia (Sidhpur Facility)

Quality StandardWHO-GMP & ISO 9001:2015

Batch Analytical COASupplied with Trade Invoice

Active Medical Composition

AZINUS-200 features Azithromycin 200mg Oral Suspension prepared to high pharmaceutical purity standards.

Therapeutic ClassificationSyrup

Regulatory ScheduleSchedule Drug (Prescription Only)

*Disclaimer: Formulations are intended solely for distribution to licensed practitioners, hospitals, and pharmacies. Dosage must adhere to medical advice.

Monopoly PCD Franchise

Apply for Exclusive Marketing Rights of AZINUS-200

Check vacant territory availability in your state or district. Enjoy full marketing kit support, visual aids, and guaranteed zero competitor supply.

Distributor Inquiries

Questions Regarding AZINUS-200

What is the therapeutic indication and composition of AZINUS-200?

AZINUS-200 contains Azithromycin 200mg Oral Suspension indicated for Lower Respiratory Tract Infections as formulated by Sygnus Biotech.

What packaging presentations are available for AZINUS-200?

AZINUS-200 is supplied in tamper-evident 100ml / 200ml PET Bottle with Graduated Measuring Cap, engineered with barrier foil protection to ensure a 24 to 36 month shelf life.

Is monopoly PCD franchise territory available for AZINUS-200?

Yes, Sygnus Biotech grants exclusive district-wise monopoly marketing rights for AZINUS-200 along with promotional visual aids, product cards, and marketing support.